2B5E

ICD-11 MMS 2026-01

Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site
  • Malignant triton tumour of peripheral nerves or autonomic nervous system
  • Malignant nerve sheath tumour of peripheral nerves of head, face or neck
Show allHide
  • Malignant nerve sheath tumour of peripheral nerves of upper limb, including shoulder
  • Malignant nerve sheath tumours of peripheral nerves of lower limb, including hip
  • Malignant nerve sheath tumour of peripheral nerves of thorax
  • Malignant nerve sheath tumour of peripheral nerves of abdomen
  • Malignant nerve sheath tumour of peripheral nerves of pelvis
  • Malignant nerve sheath tumour involving overlapping sites of peripheral nerves or autonomic nervous system

Excludes

  • 2A02.10 – Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves

Exclusions from above levels

  • 2A01.1 – Mesenchymal tumour of meninges
  • 2A02.1 – Tumours of cranial or paraspinal nerves
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2B50 – Chondrosarcoma, primary site
  • 2B51 – Osteosarcoma, primary site
  • 2B52 – Ewing sarcoma, primary site
  • 2B53 – Fibroblastic or myofibroblastic tumour, primary site
  • 2B54 – Undifferentiated pleomorphic sarcoma, primary site
  • 2B55 – Rhabdomyosarcoma, primary site
  • 2B56 – Angiosarcoma, primary site
  • 2B57 – Kaposi sarcoma, primary site
  • 2B58 – Leiomyosarcoma, primary site
  • 2B59 – Liposarcoma, primary site
  • 2B5A – Synovial sarcoma, primary site
  • 2B5B – Gastrointestinal stromal tumour, primary site
  • 2B5C – Endometrial stromal sarcoma, primary site
  • 2B5D – Malignant mixed epithelial mesenchymal tumour, primary site
  • 2B5F – Sarcoma, not elsewhere classified, primary site
  • 2B5G – Myosarcoma of uterus, part not specified
  • 2B5H – Well differentiated lipomatous tumour, primary site
  • 2B5J – Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites
  • 2B5K – Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites
  • 2B5Y – Other specified malignant mesenchymal neoplasms
  • 2B5Z – Malignant mesenchymal neoplasm of unspecified type

Foundation entity

Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site – http://id.who.int/icd/entity/979754709

Allowed postcoordination axes

Part of: 02: Neoplasms